Nissui Of Japan To Market Fast Test For Seafood Allergen
This article was originally published in PharmAsia News
Japan's Nissui Pharmaceutical says it has worked with a major seafood giant to develop a quick test for determining whether people have an allergic reaction to shrimp or crabs. Japanese law requires labels on those seafoods to state whether they contain the protein tropomyosin. Nissui, which makes reagents, is affiliated with Nippon Suisan Kaisha, a seafood dealer. Nissui plans to begin marketing the kit to food manufacturers that run different foods on the same production line to check for accidental contamination. (Click here for more - a subscription may be required
You may also be interested in...
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.